Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 7
1964 9
1965 2
1966 4
1967 6
1968 14
1969 23
1970 24
1971 28
1972 46
1973 32
1974 30
1975 30
1976 41
1977 26
1978 21
1979 25
1980 30
1981 31
1982 31
1983 36
1984 40
1985 51
1986 36
1987 42
1988 47
1989 55
1990 67
1991 64
1992 57
1993 66
1994 71
1995 89
1996 62
1997 62
1998 85
1999 116
2000 101
2001 142
2002 190
2003 177
2004 245
2005 259
2006 331
2007 318
2008 355
2009 320
2010 391
2011 426
2012 450
2013 566
2014 580
2015 603
2016 723
2017 750
2018 732
2019 776
2020 987
2021 1047
2022 1035
2023 1070
2024 268

Text availability

Article attribute

Article type

Publication date

Search Results

12,902 results

Results by year

Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.
Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D. Pouwels S, et al. BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1. BMC Endocr Disord. 2022. PMID: 35287643 Free PMC article. Review.
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public health. ...Histologic evaluation with liver biopsy remains the gold standard to …
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver diseas …
Hepatic Steatosis: Etiology, Patterns, and Quantification.
Idilman IS, Ozdeniz I, Karcaaltincaba M. Idilman IS, et al. Semin Ultrasound CT MR. 2016 Dec;37(6):501-510. doi: 10.1053/j.sult.2016.08.003. Epub 2016 Aug 12. Semin Ultrasound CT MR. 2016. PMID: 27986169 Review.
Hepatic steatosis can occur because of nonalcoholic fatty liver disease (NAFLD), alcoholism, chemotherapy, and metabolic, toxic, and infectious causes. Pediatric hepatic steatosis is also becoming more frequent and can have distinctive fe …
Hepatic steatosis can occur because of nonalcoholic fatty liver disease (NAFLD), alcoholism, chemotherapy, and m …
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.
Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Ipsen DH, et al. Cell Mol Life Sci. 2018 Sep;75(18):3313-3327. doi: 10.1007/s00018-018-2860-6. Epub 2018 Jun 23. Cell Mol Life Sci. 2018. PMID: 29936596 Free PMC article. Review.
This narrative review investigates the molecular mechanisms of hepatic steatosis in NAFLD, focusing on the four major pathways contributing to lipid homeostasis in the liver. Hepatic steatosis is a consequence of lipid acquisition exceeding lipi …
This narrative review investigates the molecular mechanisms of hepatic steatosis in NAFLD, focusing on the four major pathways …
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis.
Lee KC, Wu PS, Lin HC. Lee KC, et al. Clin Mol Hepatol. 2023 Jan;29(1):77-98. doi: 10.3350/cmh.2022.0237. Epub 2022 Oct 13. Clin Mol Hepatol. 2023. PMID: 36226471 Free PMC article. Review.
Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stellate cells, exacerbating hepatic steatosis, inflammation, and fibrosis. Bile acids regulate glucose and lipid metabolism through …
Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stella …
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.
Guo X, Yin X, Liu Z, Wang J. Guo X, et al. Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489. Int J Mol Sci. 2022. PMID: 36555127 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, affecting approximately one-quarter of the global population, and has become a world public health issue. NAFLD is a clinicopathological syndrome characterized by hepati …
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, affecting approximately one-quar …
[Nonalcoholic hepatic steatosis: a silent disease].
Aguilera-Méndez A. Aguilera-Méndez A. Rev Med Inst Mex Seguro Soc. 2019 Mar 15;56(6):544-549. Rev Med Inst Mex Seguro Soc. 2019. PMID: 30889343 Review. Spanish.
Alteration of hepatic lipid metabolism can originate an excessive accumulation of lipids and lead to hepatic steatosis emergence and when not related to chronic alcohol consumption, it is known as non-alcoholic fatty liver disease. ...In this re …
Alteration of hepatic lipid metabolism can originate an excessive accumulation of lipids and lead to hepatic steatosis …
Hepatic lipid droplet homeostasis and fatty liver disease.
Seebacher F, Zeigerer A, Kory N, Krahmer N. Seebacher F, et al. Semin Cell Dev Biol. 2020 Dec;108:72-81. doi: 10.1016/j.semcdb.2020.04.011. Epub 2020 May 20. Semin Cell Dev Biol. 2020. PMID: 32444289 Review.
In cells, lipids are stored in lipid droplets, dynamic organelles that adapt their size, abundance, lipid and protein composition and organelle interactions to metabolic changes. Lipid droplet accumulation in the liver is the hallmark of non-alcoholic fatty liver …
In cells, lipids are stored in lipid droplets, dynamic organelles that adapt their size, abundance, lipid and protein composition and organe …
Nonalcoholic Fatty Liver Disease.
Wang XJ, Malhi H. Wang XJ, et al. Ann Intern Med. 2018 Nov 6;169(9):ITC65-ITC80. doi: 10.7326/AITC201811060. Ann Intern Med. 2018. PMID: 30398639 Review.
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. Most cases are diagnosed incidentally in the primary care or hospital setting on the basis of elevated liver enzyme levels or hepatic steatosis on ima …
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. Most cases are diagnosed incide …
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
Carr RM, Oranu A, Khungar V. Carr RM, et al. Gastroenterol Clin North Am. 2016 Dec;45(4):639-652. doi: 10.1016/j.gtc.2016.07.003. Epub 2016 Oct 13. Gastroenterol Clin North Am. 2016. PMID: 27837778 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) is an important cause of morbidity and mortality worldwide and is rapidly becoming the leading cause of end-stage liver disease and liver transplant. ...The pathogenesis includes the roles of hormones, nutrition …
Nonalcoholic fatty liver disease (NAFLD) is an important cause of morbidity and mortality worldwide and is rapidly becoming th …
Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.
Horn CL, Morales AL, Savard C, Farrell GC, Ioannou GN. Horn CL, et al. Hepatol Commun. 2022 Jan;6(1):12-35. doi: 10.1002/hep4.1801. Epub 2021 Aug 24. Hepatol Commun. 2022. PMID: 34558856 Free PMC article. Review.
The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related cirrhosis in the United States and globally highlights the need to better understand the mechanisms causing progression of hepatic steatosis to fibrosing steatohepatiti …
The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related cirrhosis in the United States and globall …
12,902 results
You have reached the last available page of results. Please see the User Guide for more information.